In June 2020, BSV formed a strategic alliance with LaVoieHealthScience in order to enhance BSV's capabilities to communicate value. <read more here>                     In May 2020, BSV entered into a strategic alliance with FCF Fox Corporate Finance to support funding activities. <read more here>                    
 
                           COVID-19 Portal               Home      About      Team      Clients      Publications      Downloads      News      Career      Contact

Testimonials
  Through its 'Corporate Partnership Program', Bioscience Valuation has provided exceptional support in the transformation of our business model. BSV's evidence-based assessments proved invaluable for our strategic decision making as well as for preparing our corporate transactions.

Peter Llewellyn-Davies, CFO/CBO
Medigene AG

 

Core Services
  Financial Valuation
  Commercial Assessment &
Pharmacoeconomics

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

Products
  Market Model
  R&D Risk Model
  Valuation Model

Core Services - Commercial Assessment

Bioscience Valuation's Commercial Assessment covers
  • in-depth analysis of disease market, standard of care and medical need,
  • definition of target product profile (TPP),
  • forecast of incidence and prevalence,
  • detailed analysis of competitors (launched and in development),
  • a pharmacoeconomic assessment,
  • determination of a product's optimal price range and likely market share,
  • if ordered, primary market research,
  • sales forecast until patent expiry.
Core Services - Pharmacoeconomics

An early Pharmacoeconomic Assessment

  • determines a drug's incremental cost - effectiveness ratio (ICER) based on its TPP,
  • shows whether a TPP needs improvement to ensure cost - effectiveness,
  • supports management in determining a drug's market price that will likely get reimbursed.

Case:
A 'top 20' multinational pharmaceutical company asked us to perform commercial assessments for their in-licensing candidates. The client expects comprehensive analyses, adhering to the company's highest quality standards.

Our assessments provide the expected analysis that frees up the client's resources to focus on decision-making and internal communications.




This website uses cookies to ensure you get the best experience on our website.
Privacy Policy